Status:
UNKNOWN
Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19
Lead Sponsor:
Heidelberg University
Conditions:
SARS-CoV2
COVID
Eligibility:
All Genders
18+ years
Brief Summary
Approximately 15% of patients with SARS-CoV-2 infection / COVID-19 develop a severe clinical course. This leads to hospitalization and potentially life threatening complications such as pneumonia and ...
Eligibility Criteria
Inclusion
- SARS-CoV-2 infection / COVID 19
Exclusion
- invasive ventilation
- respiratory failure at admission
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04456075
Start Date
April 1 2020
End Date
April 1 2022
Last Update
July 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thoraxklinik at Heidelberg University
Heidelberg, Germany, 69126